Marksans Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 321.74 | 305.99 | 334.37 |
| Operating Expense | 249.68 | 247.60 | 251.93 |
| Net Profit | 48.06 | 37.59 | 55.46 |
| Net Profit Margin | 14.94 | 12.28 | 16.59 |
| Earning Per Share | 1.06 | 0.83 | 1.22 |
| EBIDTA | 71.09 | 57.64 | 80.80 |
| Effective Tax Rate | 20.18 | 19.80 | 21.37 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 321.74 |
| Operating Expense | 249.68 |
| Net Profit | 48.06 |
| Net Profit Margin | 14.94 |
| Earning Per Share | 1.06 |
| EBIDTA | 71.09 |
| Effective Tax Rate | 20.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,174.37 | 853.27 | 655.20 |
| Operating Expenses Annual | 970.32 | 713.34 | 563.30 |
| Operating Profit Annual | 273.89 | 202.01 | 152.39 |
| Interest Annual | 1.17 | 0.99 | 3.61 |
| Depreciation | 28.75 | 27.21 | 16.15 |
| Net Profit Annual | 188.27 | 133.76 | 102.87 |
| Tax Annual | 54.99 | 38.13 | 29.17 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,174.37 |
| Operating Expenses Annual | 970.32 |
| Operating Profit Annual | 273.89 |
| Interest Annual | 1.17 |
| Depreciation | 28.75 |
| Net Profit Annual | 188.27 |
| Tax Annual | 54.99 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 41.93 | 148.31 | 81.19 |
| Cash Flow from Operations | 31.02 | 34.05 | 51.73 |
| Cash Flow from Investing | 17.24 | -114.22 | -194.62 |
| Cash Flow from Financing | -29.92 | -26.22 | 210.02 |
| Cash Flow at the End | 60.27 | 41.93 | 148.31 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 41.93 |
| Cash Flow from Operations | 31.02 |
| Cash Flow from Investing | 17.24 |
| Cash Flow from Financing | -29.92 |
| Cash Flow at the End | 60.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 23.32 | 23.67 | 23.26 |
| PBIT Margin (%) | 20.81 | 20.26 | 20.70 |
| PBT Margin (%) | 3.02 | -0.21 | 14.96 |
| Net PROFIT Margin (%) | 16.03 | 15.68 | 15.70 |
| Return On Networth / Equity (%) | 14.45 | 11.46 | 10.85 |
| Return On Networth /Employed (%) | 18.55 | 14.67 | 14.11 |
| Return On Assets (%) | 14.27 | 11.29 | 10.68 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 0.89 | 0.72 | 0.68 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 23.32 |
| PBIT Margin (%) | 20.81 |
| PBT Margin (%) | 3.02 |
| Net PROFIT Margin (%) | 16.03 |
| Return On Networth / Equity (%) | 14.45 |
| Return On Networth /Employed (%) | 18.55 |
| Return On Assets (%) | 14.27 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.89 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 383.37 | 271.58 | 143.94 |
| Total Current Assets Annual | 1,082.22 | 947.70 | 913.76 |
| Non Current Assets Annual | 673.08 | 568.33 | 431.10 |
| Total Shareholders Funds Annual | 1,383.49 | 1,222.71 | 1,111.32 |
| Total Assets Annual | 1,755.30 | 1,516.04 | 1,344.86 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 383.37 |
| Total Current Assets Annual | 1,082.22 |
| Non Current Assets Annual | 673.08 |
| Total Shareholders Funds Annual | 1,383.49 |
| Total Assets Annual | 1,755.30 |
EPS (INR)
Expected
1.29
Reported
1.29
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
